Online citations, reference lists, and bibliographies.
← Back to Search

Phase II Study Of First-line Bortezomib And Cisplatin In Malignant Pleural Mesothelioma And Prospective Validation Of Progression Free Survival Rate As A Primary End-point For Mesothelioma Clinical Trials (European Organisation For Research And Treatment Of Cancer 08052)

Mary E.R. O’Brien, Rabab M. Gaafar, Sanjay Popat, Francesco Grossi, Allan Price, Denis C. Talbot, Tanja Cufer, Christian Ottensmeier, Sarah Danson, Athanasios Pallis, Baktiar Hasan, Jan P. Van Meerbeeck, Paul Baas

Save to my Library
Download PDF
Analyze on Scholarcy
Share